A Case Report: Addison’s Disease in a Patient with Hypothyroidism and Vitiligo, A Suspected Case of Autoimmune Polyendocrine Syndrome Type 2

Authors

  • Pheeraya Sutheravut Institute of Dermatology, Bangkok, Thailand.
  • Sasima Thammarucha Institute of Dermatology, Bangkok, Thailand.
  • Poonnawis Sudtikoonaseth Institute of Dermatology, Bangkok, Thailand.

Keywords:

Addison’s disease, Autoimmune polyendocrine syndrome, Autoimmune polyglandular syndrome

Abstract

Addison’s disease, or primary adrenal insufficiency, is characterized by diffused hyperpigmentation, weight loss, and low blood pressure. The diagnosis of this condition is based on laboratory tests with low serum cortisol and high serum adrenocorticotropic hormone. In terms of management, diagnostic workups and treatment of specific causes, as well as hormone replacement therapy, should be considered. We reported a case of a 41-year-old Thai female with a gradual onset of generalized darkening of the skin, accompanied by other autoimmune presentations, including autoimmune thyroiditis and vitiligo. The aforementioned findings have led to suspicion of autoimmune polyendocrine syndrome type 2.

References

Chakera AJ, Vaidya B. Addison disease in adults: diagnosis and management. Am J Med 2010;123:409-13.

Munir S, Quintanilla Rodriguez BS, Waseem M. Addison Disease. StatPearls. Treasure Island (FL): StatPearls PublishingCopyright© 2022, StatPearls Publishing LLC.; 2022.

Husebye ES, Anderson MS, Kämpe O. Autoimmune Polyendocrine Syndromes. N Engl J Med 2018;378:1132-41.

Agrawal SN, Deshmukh YR, Jane SD, Rawal AA. Addison’s Disease: A rare case report. Our Dermatology Online 2015;6:193-5.

Burton C, Cottrell E, Edwards J. Addison’s disease: identification and management in primary care. British Journal of General Practice 2015;65:488.

Puttanna A, Cunningham AR, Dainty P. Addison's disease and its associations. BMJ Case Rep 2013;2013.

Pazderska A, Pearce SH. Adrenal insufficiency - recognition and management. Clin Med (Lond) 2017;17:258-62.

Nieman LK, Chanco Turner ML. Addison's disease. Clin Dermatol 2006;24:276-80.

Fernandez-Flores A, Cassarino DS. Histopathologic Findings of Cutaneous Hyperpigmentation in Addison Disease and Immunostain of the Melanocytic Population. Am J Dermatopathol 2017;39:924-7.

Gaba N, Gaba S, Singla M, Gupta M. Type 2 Autoimmune Polyglandular Syndrome Presenting with Hyperpigmentation and Amenorrhea. Cureus 2020;12:e7772.

Benner BJM, Alsma J, Feelders RA. Hyponatraemia and hyperpigmentation in primary adrenal insufficiency. BMJ Case Reports 2019;12:e227200.

Chen H, Hsieh F-N, Yang C-C. Mucocutaneous hyperpigmentation as a clue to diagnose Addison disease – Two case reports. Dermatologica Sinica 2022;40:48-9.

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016;101:364-89.

Downloads

Published

2023-03-09

How to Cite

Sutheravut, P., Thammarucha, S., & Sudtikoonaseth, P. (2023). A Case Report: Addison’s Disease in a Patient with Hypothyroidism and Vitiligo, A Suspected Case of Autoimmune Polyendocrine Syndrome Type 2. Thai Journal of Dermatology, 39(1), 21–25. Retrieved from https://he02.tci-thaijo.org/index.php/TJD/article/view/260005

Issue

Section

Case Report